Assessing the diagnostic performance of investigations in pediatric myoclonic epilepsies: A retrospective cohort study.

IF 6.6 1区 医学 Q1 CLINICAL NEUROLOGY
Epilepsia Pub Date : 2025-03-28 DOI:10.1111/epi.18383
Sophie Brulé, Blandine Dozières-Puyravel, Hala Nasser, Monique Elmaleh-Bergès, François-Xavier Mauvais, Stéphane Auvin
{"title":"Assessing the diagnostic performance of investigations in pediatric myoclonic epilepsies: A retrospective cohort study.","authors":"Sophie Brulé, Blandine Dozières-Puyravel, Hala Nasser, Monique Elmaleh-Bergès, François-Xavier Mauvais, Stéphane Auvin","doi":"10.1111/epi.18383","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The primary purpose was to assess the diagnostic performance of investigations in children with myoclonic epilepsy. The secondary objectives were to examine the definitive syndromic diagnoses and report the outcomes of pediatric myoclonic epilepsies.</p><p><strong>Methods: </strong>We conducted a retrospective monocentric study from a pediatric center for rare epilepsies. We included pediatric patients investigated for myoclonic epilepsy at our center from 2009 to 2022. Data were collected from their medical records.</p><p><strong>Results: </strong>Forty-one children were included; 32 (78%) underwent untargeted etiological investigations, including brain magnetic resonance imaging and diverse laboratory tests to rule out an underlying etiology for progressive myoclonus epilepsy (PME). These investigations led to an etiological diagnosis of epilepsy for two patients, exclusively based on genetic investigations. At the final follow-up, an underlying etiology for epilepsy was established for nine patients (22%). The definitive syndromic diagnoses were diverse, comprising myoclonic epilepsy in infancy, epilepsy with myoclonic absences, Rasmussen syndrome, and PME. Some patients were diagnosed with nonsyndromic developmental and epileptic encephalopathy or unclassified nonsyndromic myoclonic epilepsy. Developmental delay or regression at the initial evaluation was found to be significantly associated with an unfavorable neurological outcome, the total number of antiseizure medications (ASMs) prescribed, and the unlikelihood of achieving ASM freedom. No patients with an abnormal head circumference or born of a consanguineous union were in the favorable neurological outcome group, although this finding did not reach statistical significance.</p><p><strong>Significance: </strong>Except for the need to promptly identify diseases for which precision medicine treatments are available, a first-line genetic approach seems reasonable to investigate children diagnosed with epileptic myoclonus.</p>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/epi.18383","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The primary purpose was to assess the diagnostic performance of investigations in children with myoclonic epilepsy. The secondary objectives were to examine the definitive syndromic diagnoses and report the outcomes of pediatric myoclonic epilepsies.

Methods: We conducted a retrospective monocentric study from a pediatric center for rare epilepsies. We included pediatric patients investigated for myoclonic epilepsy at our center from 2009 to 2022. Data were collected from their medical records.

Results: Forty-one children were included; 32 (78%) underwent untargeted etiological investigations, including brain magnetic resonance imaging and diverse laboratory tests to rule out an underlying etiology for progressive myoclonus epilepsy (PME). These investigations led to an etiological diagnosis of epilepsy for two patients, exclusively based on genetic investigations. At the final follow-up, an underlying etiology for epilepsy was established for nine patients (22%). The definitive syndromic diagnoses were diverse, comprising myoclonic epilepsy in infancy, epilepsy with myoclonic absences, Rasmussen syndrome, and PME. Some patients were diagnosed with nonsyndromic developmental and epileptic encephalopathy or unclassified nonsyndromic myoclonic epilepsy. Developmental delay or regression at the initial evaluation was found to be significantly associated with an unfavorable neurological outcome, the total number of antiseizure medications (ASMs) prescribed, and the unlikelihood of achieving ASM freedom. No patients with an abnormal head circumference or born of a consanguineous union were in the favorable neurological outcome group, although this finding did not reach statistical significance.

Significance: Except for the need to promptly identify diseases for which precision medicine treatments are available, a first-line genetic approach seems reasonable to investigate children diagnosed with epileptic myoclonus.

评估小儿肌阵挛性癫痫检查的诊断效果:回顾性队列研究
目的:主要目的是评估肌阵挛性癫痫患儿的检查诊断结果。次要目的是检查明确的综合征诊断,并报告小儿肌阵挛性癫痫的治疗结果:我们在一家罕见癫痫儿科中心开展了一项回顾性单中心研究。我们纳入了 2009 年至 2022 年期间在本中心接受肌阵挛性癫痫检查的儿科患者。数据来自他们的病历:结果:共纳入41名儿童,其中32名(78%)接受了无针对性的病因学检查,包括脑磁共振成像和各种实验室检查,以排除进行性肌阵挛癫痫(PME)的潜在病因。通过这些检查,两名患者被确诊为癫痫,而这完全是基于基因检查。在最后的随访中,9 名患者(22%)的癫痫病因得到确定。明确的综合征诊断多种多样,包括婴儿期肌阵挛性癫痫、肌阵挛性失神癫痫、拉斯穆森综合征和 PME。一些患者被诊断为非综合征发育和癫痫性脑病或未分类的非综合征肌阵挛性癫痫。初步评估发现,发育迟缓或倒退与不利的神经系统预后、抗癫痫药物(ASM)的处方总数以及获得ASM自由的可能性显著相关。头围异常或近亲结婚的患者均不属于神经系统预后良好组,但这一结果未达到统计学意义:意义:除了需要及时发现可进行精准医学治疗的疾病外,采用一线遗传学方法来研究确诊为癫痫性肌阵挛的儿童似乎是合理的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epilepsia
Epilepsia 医学-临床神经学
CiteScore
10.90
自引率
10.70%
发文量
319
审稿时长
2-4 weeks
期刊介绍: Epilepsia is the leading, authoritative source for innovative clinical and basic science research for all aspects of epilepsy and seizures. In addition, Epilepsia publishes critical reviews, opinion pieces, and guidelines that foster understanding and aim to improve the diagnosis and treatment of people with seizures and epilepsy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信